Kenya is moving closer to producing its first locally manufactured immunisation vaccines, with the initial trial batch expected by the end of 2027. This follows the completion of the first phase of enabling works at the Kenya BioVax Institute’s new manufacturing plant in Embakasi. The earliest beneficiaries will be newborns, who are set to receive […]